Steve Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Stanton Sloane, President and CEO
Thank you, Stan, and good afternoon. The nine months ended January 31, 2021 consolidated revenue was $38.6 million, up 24% compared to $31.3 million for the same period of the prior year. The components of revenue are as follows; revenue from commercial and U.S. government satellite programs was $20.1 million compared to $14.7 million for the same period of the prior fiscal year and accounted for approximately 52% of consolidated revenue compared to 47% for the same period of the prior fiscal year. Revenue on satellite payload contracts are recognized primarily under the percentage of completion method and a recorded only in the New York segment. Revenues from non-space U.S. government and DoD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments were $16.3 million compared to $12.7 million in the same period of the prior fiscal year and accounted for approximately 42% of consolidated revenue compared to 41% for the prior fiscal year. Other commercial and industrial revenues were $2.2 million compared to $3.9 million in the prior fiscal year. Intersegment revenues are eliminated in consolidation. For the nine month period ending January 31, 2021, gross margin and gross margin rate increased significantly as compared to the same period in fiscal year 2020. The increase in gross margin and gross margin rate was due to several programs identified in prior periods that had higher engineering costs incurred that were in the development phase, that have since been completed or are near completion. For the nine months ending January 31, 2021 and 2020, selling and administrative expenses were approximately 25% and 27% respectively of consolidated revenues. The increase in SG&A expense was mainly due to an increase in professional fees relating to litigation. R&D expense for the nine months ending January 31, 2021 and 2020 decreased to $3.5 million from $4.8 million, a decrease of $1.3 million and were 9% and 15% of consolidated revenue. The company's R&D expense decreased year-over-year as previous R&D efforts have ended and turned into production. However, the company plans to continue to invest in R&D to keep its products at the state-of-the-art. For the nine months ended January 31st, 2021, the company recorded an operating loss of $1.1 million compared to $7.3 million in the prior year. Operating loss has made a significant improvement from the same period of the prior fiscal year and reflects improvement in revenues, gross margin and gross margin rate. Based upon our bookings and backlog, we are expecting this improving trend to continue. Other income consisted primarily investment income derived from the company's holdings of marketable securities. For the nine months period ending January 31, 2021 investment income included $105,000 dividend from Morion compared to $250,000 dividend from Morion in the same period in fiscal 2020. This yields pre-tax loss of approximately $695,000 compared to a pre-tax loss of approximately $7 million for the prior year. For the nine months ending January 31, 2021, the company recorded a tax provision of $37,000 compared to $48,000 for the same period of fiscal 2020. Consolidated loss for the nine months ending January 31, 2021 was $732, 000 or $0.08 per diluted share compared to a consolidated net loss of $7.1 million or $0.78 per diluted share in the previous year. Our fully-funded backlog at the end of January, 2021 was approximately $41 million up approximately $5 million from the previous year-end April 30, 2020. The company's balance sheet continues to reflect the strong working capital position of approximately $39 million at January 31, 2021 and a current ratio of approximately 6.6 to 1. Additionally, the company is debt-free. The company believes that its liquidity is adequate to meet its operating and investing needs for the next 12 months and the foreseeable future. I will turn the call back to Stan and we look forward to your questions.